CD44 and Alzheimer disease: Our further analysis of the expression levels of relevant genes in the MIF pathway across various cell subpopulations led us to hypothesize that MIF expressed by inflammatory fibroblasts could bind to CD74 and CD44 in myeloid cells, thereby promoting inflammatory responses and exacerbating the disease progression of AD (Figure 2D).